PARP Inhibitors: Best Practices In Advanced Prostate Cancer Care In The Community
AUAUniversity5 Touko 2021

PARP Inhibitors: Best Practices In Advanced Prostate Cancer Care In The Community

This educational series is supported by independent educational grants from AstraZeneca and Merck. CME Available: https://auau.auanet.org/node/31224 Course Description: PARP Inhibitors: From Research to Practice, an exciting new educational initiative, is a series of three interactive, case-based, live virtual courses, featuring a unique topic related to PARP Inhibitors. For each session, a Moderator will engage two other subject matter experts in an interactive, interview-style presentation and discussion. Based on the documented need from the 2019 AUA global needs assessment in advanced prostate cancer, the AUA has produced a new series of educational offerings for the urologic care team focused on PARP inhibitors (PARPi). The first of three in the series PARP Inhibitors: Assessing the Rapidly Evolving Treatment Landscape will address the latest developments in PARPi treatments and advanced prostate cancer care. Upon completion of this activity, participants will be able to: 1. Describe the components of a multidisciplinary urologic cancer clinic and identify the best structure for the practice. 2. Identify opportunities for shared care and team-based approaches of patients with advanced prostate cancer. 3. Discuss the impact of shared-decision making on patient and on patient-clinician communication. 4. Describe how telemedicine can be successfully incorporated into the care continuum of patients with advanced prostate cancer.

Jaksot(422)

AUA2018 078IC - Management of Prostate Cancer: A Case Based Approach

AUA2018 078IC - Management of Prostate Cancer: A Case Based Approach

This course will provide a practical, evidence-based approach for the management of everyday problems in the management of prostate cancer, using a case-based approach with examples from real practice...

9 Elo 20182h 4min

AUA2018 019IC: Immunotherapy for the Urologist: Basic Principles, Adverse Effects & Drug Delivery

AUA2018 019IC: Immunotherapy for the Urologist: Basic Principles, Adverse Effects & Drug Delivery

The goal of the course is to provide both a basic and real-world application of immunotherapy for genitourinary oncology. The course is directed towards the urologist with an interest, but no prior ex...

1 Elo 20181h 55min

AUA2018 063IC - Prostate Cancer Update

AUA2018 063IC - Prostate Cancer Update

This course will offer a review of what faculty believe are the most important articles in the English-speaking literature on prostate cancer from May 2017 to April 2018. Focus will be placed on artic...

29 Heinä 20181h 59min

AUA2018 005IC - Chemotherapy and Immunotherapy Options for Genitourinary :A Primer for the APP

AUA2018 005IC - Chemotherapy and Immunotherapy Options for Genitourinary :A Primer for the APP

Review of current chemotherapy and immunotherapy regimens for genitourinary malignancies, including bladder, renal, and prostate cancers. Indications, outcomes, and toxicities will be discussed as wel...

25 Heinä 20181h 54min

AUA2018 058IC - Management of Common Dilemmas in Prostate Cancer Diagnosis, Staging and Treatment

AUA2018 058IC - Management of Common Dilemmas in Prostate Cancer Diagnosis, Staging and Treatment

We will discuss common PSA dilemmas: 1. Who should be screened? 2. What is the role of MRI in biopsy naive and men with prior negative biopsy? 3. What other markers can be used to determine whether bi...

11 Heinä 20182h 1min

Highlights in Renal Cell Carcinoma: Coordination of Care & the Patient's Journey (2018)

Highlights in Renal Cell Carcinoma: Coordination of Care & the Patient's Journey (2018)

The "Live from AUA2018" Highlights in Renal Cell Carcinoma series is comprised of three panel discussions which will focus on: Discussing the evolving landscape of adjuvant therapy for the treatment ...

5 Heinä 201831min

AUA2018 031IC: Contemporary Pharmacotherapy for OAB

AUA2018 031IC: Contemporary Pharmacotherapy for OAB

Much has been written and debated about drug treatment of overactive bladder (OAB) over the past two decades. Nevertheless, the field continues to evolve. OAB pharmacotherapy remains an area of active...

23 Kesä 20182h 12min

Focal Therapy Interview with John W. Davis, MD, FACS

Focal Therapy Interview with John W. Davis, MD, FACS

Dr. Nitti and Dr. Davis discus the use of focal therapy in the treatment of prostate cancer. @jdhdavis - This file has been updated

15 Kesä 201833min

Suosittua kategoriassa Koulutus

rss-murhan-anatomia
psykopodiaa-podcast
voi-hyvin-meditaatiot-2
rss-narsisti
rss-niinku-asia-on
adhd-podi
rss-liian-kuuma-peruna
aamukahvilla
psykologia
rss-valo-minussa-2
rss-vapaudu-voimaasi
kesken
rss-koira-haudattuna
aloita-meditaatio
dear-ladies
esa-saarinen-filosofia-ja-systeemiajattelu
ihminen-tavattavissa-tommy-hellsten-instituutti
leveli
rss-luonnollinen-synnytys-podcast
filocast-filosofian-perusteet